Second primary malignancies in multiple myeloma: an overview and IMWG consensus
Musto, P., Anderson, K.C., Attal, M., Richardson, P.G., Badros, A., Hou, J., Comenzo, R., Du, J., Durie, B.G.M., San Miguel, J., Einsele, H., Chen, W.M., Garderet, L., Pietrantuono, G., Hillengass, J., Kyle, R.A., Moreau, P., Lahuerta, J.J., Landgren, O., Ludwig, H., Larocca, A., Mahindra, A., Cavo, M., Mazumder, A., McCarthy, P.L., Nouel, A., Rajkumar, S.V., Reiman, A., Riva, E., Sezer, O., Terpos, E., Turesson, I., Usmani, S., Weiss, B.M., Palumbo, A.
Published in Annals of oncology (01.02.2017)
Published in Annals of oncology (01.02.2017)
Get full text
Journal Article
HDAC Inhibition in Multiple Myeloma with a Focus on Selective HDAC6 Inhibition
Raje, N, Yee, A.J, Richardson, P.G
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS
Capra, M.E.Z., Beksac, M., Richardson, P.G., Unal, A., Corradini, P., Delimpasi, S., Gulbas, Z., Mikala, G., Neylon, A., Symeonidis, A., Bringhen, S., Moreau, P., Velde, H.V., Campana, F., Guennec, S.L., Spicka, I.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
The current unmet medical needs in the treatment and management of multiple myeloma (MM)
Richardson, P.G, Palumbo, A, Mateos, M.-V, van de Velde, H, Skacel, T, Lonial, S
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Debate - Change Therapy for High/Low Risk Patients - No
Richardson, P.G, Laubach, J, Paba-Prada, C, Schlossman, R, Ghobrial, I, Tai, Y, Munshi, N, Anderson, K
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
S824 A PHASE 3 RANDOMIZED, OPEN‐LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW‐DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW‐DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Attal, M., Richardson, P.G., Rajkumar, S.V., San‐Miguel, J., Beksac, M., Spicka, I., Leleu, X., Schjesvold, F., Moreau, P., Dimopoulos, M.A., Huang, J.S.‐Y., Minarik, J., Cavo, M., Prince, H.M., Mace, S., Corzo, K.P., Campana, F., Le‐Guennec, S., Dubin, F., Anderson, K.C.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study
Prada, C.P, Shain, K.H, Voorhees, P, Gabrail, N, Abidi, M, Zonder, J, Boccia, R, Richardson, P.G, Neuman, L, Wong, H, Dixon, S, Hari, P
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Ibrutinib in combination with low-dose dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: results from a multicenter phase 2 trial
Richardson, P.G, Bensinger, W.I, Huff, C.A, Costello, C.L, Lendvai, N, Berdeja, J.G, Anderson, L.D, Siegel, D.S, Jagannath, S, Laubach, J.P, Stockerl-Goldstein, K.E, Knapp, L, Kwei, L, Clow, F, Graef, T, Bilotti, E, Vij, R
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Subgroup Analysis by Prior Treatment of the Efficacy and Safety of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma in the PANORAMA 1 Study
Richardson, P.G, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Bengoudifa, B.R, Corrado, C, San-Miguel, J.F
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104
Holstein, S.A, Owzar, K, Richardson, P.G, Jiang, C, Hofmeister, C.C, Hassoun, H, Hurd, D.D, Stadtmauer, E.A, Giralt, S, Devine, S.M, Hars, V, Postiglione, J, Weisdorf, D.J, Vij, R, Moreb, J.S, Callander, N.S, Pasquini, M.C, Martin, T.G, Shea, T.C, Anderson, K, McCarthy, P.L
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Impact of Treatment Duration and Dosing on Efficacy and Safety in a Phase 3 Study of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
San-Miguel, J.F, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Redhu, S, Paul, S, Corrado, C, Binlich, F, Richardson, P.G
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Novel Insights to Pathogenesis, Current Status of Treatment, and Future Directions
Richardson, P.G, Ho, V.T, Cutler, C, Glotzbecker, B, Antin, J.H, Soiffer, R
Published in Biology of blood and marrow transplantation (2013)
Published in Biology of blood and marrow transplantation (2013)
Get full text
Journal Article
EE73 Ocean (OP-103): Patients with Relapsed/Refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone or Pomalidomide Plus Dexamethasone - a Resource Utilization Analysis of Adverse Events Leading to Hospitalizations
Hellem Schjesvold, F., Ludwig, H., Delimpasi, S., Robak, P., Mateos, M.V., Sandberg, A., Obermüller, J., Norin, S., Richardson, P.G., Sonneveld, P.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
Mohty, M, Malard, F, Abecassis, M, Aerts, E, Alaskar, A S, Aljurf, M, Arat, M, Bader, P, Baron, F, Bazarbachi, A, Blaise, D, Ciceri, F, Corbacioglu, S, Dalle, J-H, Duarte, R F, Fukuda, T, Huynh, A, Masszi, T, Michallet, M, Nagler, A, NiChonghaile, M, Pagluica, T, Peters, C, Petersen, F B, Richardson, P G, Ruutu, T, Savani, B N, Wallhult, E, Yakoub-Agha, I, Carreras, E
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Published in Bone marrow transplantation (Basingstoke) (01.06.2015)
Get full text
Journal Article
Web Resource
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma
Minami, J, Suzuki, R, Mazitschek, R, Gorgun, G, Ghosh, B, Cirstea, D, Hu, Y, Mimura, N, Ohguchi, H, Cottini, F, Jakubikova, J, Munshi, N C, Haggarty, S J, Richardson, P G, Hideshima, T, Anderson, K C
Published in Leukemia (01.03.2014)
Published in Leukemia (01.03.2014)
Get full text
Journal Article
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma
Kikuchi, S, Suzuki, R, Ohguchi, H, Yoshida, Y, Lu, D, Cottini, F, Jakubikova, J, Bianchi, G, Harada, T, Gorgun, G, Tai, Y-T, Richardson, P G, Hideshima, T, Anderson, K C
Published in Leukemia (01.09.2015)
Published in Leukemia (01.09.2015)
Get full text
Journal Article
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma
Breitkreutz, I, Raab, M S, Vallet, S, Hideshima, T, Raje, N, Mitsiades, C, Chauhan, D, Okawa, Y, Munshi, N C, Richardson, P G, Anderson, K C
Published in Leukemia (01.10.2008)
Published in Leukemia (01.10.2008)
Get full text
Journal Article
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials
Potts, B C, Albitar, M X, Anderson, K C, Baritaki, S, Berkers, C, Bonavida, B, Chandra, J, Chauhan, D, Cusack, Jr, J C, Fenical, W, Ghobrial, I M, Groll, M, Jensen, P R, Lam, K S, Lloyd, G K, McBride, W, McConkey, D J, Miller, C P, Neuteboom, S T C, Oki, Y, Ovaa, H, Pajonk, F, Richardson, P G, Roccaro, A M, Sloss, C M, Spear, M A, Valashi, E, Younes, A, Palladino, M A
Published in Current cancer drug targets (01.03.2011)
Published in Current cancer drug targets (01.03.2011)
Get more information
Journal Article